Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02144259 · ClinicalTrials.gov registry record · NA

The Impact of Contraception on Postpartum Weight Loss

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02144259: Completed NA study, sponsored by University of Pennsylvania.

NCT02144259 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02144259, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a series of questions, take a pregnancy test, and be weighed. Total length of participation for each subject is 1 year or until pregnancy.

Primary Outcome

Weight will be measured at 6 months postpartum. Percent weight change will be compared amongst the groups

Interventions

  • DRUG DMPA immediately postpartum
  • DRUG Implanon immediately postpartum

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2011-04
Est. Completion 2012-10
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT02144259 record still lists

NCT02144259 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which DMPA immediately postpartum is the first listed.

NCT02144259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02144259 about?

NCT02144259 is a clinical study titled "The Impact of Contraception on Postpartum Weight Loss". This is a prospective mixed methods study to assess weight changes in women randomized to receive Implanon ® or Depo Provera® (DMPA) immediately postpartum compared to women who choose non-hormonal contraception or no contraception immediately postpartum. After enrollment, subjects return for a visi...

What is the current status of trial NCT02144259?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-04. Estimated completion is 2012-10.

What interventions are being tested in trial NCT02144259?

The interventions under investigation include: DMPA immediately postpartum (DRUG), Implanon immediately postpartum (DRUG).

Who is sponsoring clinical trial NCT02144259?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02144259's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02144259, the US trial registry maintained by the National Library of Medicine. NCT02144259 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.